Biotech Breakdown: Market Selloff Should Continue, Biotech Names Looking Sketchy (10/10/14) | Marketfy

Christian Tharp

Biotech Breakdown: Market Selloff Should Continue, Biotech Names Looking Sketchy (10/10/14)

By Christian Tharp, CMT — Author

Market Analysis

S&P has broken 3-year wedge support, short-term channel support should be next
DOW looks to break wedge support
Russell has moved well below support

Biotech

IBB holding on ok, but the 265 zone is key
Broken trendlines for MDVN, ISIS and ALNY
ICPT looks like its headed towards 200 for sure.
Other biotechs discussed: AEGR, GILD, KITE, SRPT

Posted to The Biotech Trader on Oct 10, 2014 — 11:10 AM

Check out what my VIP members get

Recent free content from Christian Tharp, CMT

Biotech Breakdown: Positive Signs Are Building (11/25/15) — 11/25/15
Biotech Breakdown: Market Still Pulling Back (11/12/15) — 11/12/15
Biotech Breakdown: Market Pullback Before New Highs (11/6/15) — 11/06/15
Biotech Breakdown: Market Correction Over? (10/22/15) — 10/23/15
Biotech Breakdown: Markets Up, Biotechs Finally Take Part (10/16/15) — 10/16/15

You can also use Ctrl+Enter to post

Comments ({[comments.length]})

Sort By:

Loading Comments

No comments. Break the ice and be the first!

Error loading comments Click here to retry

No comments found matching this filter

{[comment.author.username]} {[comment.author.username]} — Marketfy Staff — Maven — Member

{[comment.date_posted|date_format]} ● {[comment.date_posted|date_ago]} ● Edited ● Edit Comment ● Delete Comment

Want to add a comment? Take me to the new comment box!